Repligen's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Repligen's ROA in the third quarter of 2026?
Repligen Corp recorded a cumulative net loss of $-12 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -0.4%.

However, within the Healthcare sector 214 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1895, from total ROA ranking in the second quarter of 2026 at 2252.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	0.09 %	1.67 %	2.76 %	9.38 %	8.06 %
Y / Y Net Income Change	-	-66.31 %	42.93 %	-	-
Net Income (TTM) in million	-12	42	51	49	2
Return On Assets (TTM)	-0.4 %	1.41 %	1.76 %	1.68 %	0.06 %
RGEN's Total Ranking	# 1895	# 2252	# 2557	# 2667	# 2737
Total Assets (TTM) in million	2,926	2,950	2,931	2,950	2,924
Seq. Total Assets Change	-0.81 %	0.66 %	-0.64 %	0.89 %	0.76 %
Seq. Net Income Change	-	-39.9 %	-37.28 %	-10.89 %	0.3 %

RGEN's 5 Years Annual ROA >> Back to RGEN Management Effectiveness >> Compare RGEN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 25
Sector	# 215
Overall	# 2582

Return On Assets Statistics
High	Average	Low
20.18 %	5.1 %	-0.9 %
(Sep 30 2013)		(Dec 31 2024)

Financial Statements
Repligen's Assets	$ 2,926 million	RGEN's Balance sheet
Repligen's Income	$ -38 million	Quarterly RGEN's Income Statement
RGEN's Income by Division		See RGEN's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	9.38 %	-0.78 %	13.2 %	6.27 %	20.23 %
Total Assets in million	2,950	2,697	2,718	2,401	2,259
Y / Y Net Income Change	-	-	-80.86 %	44.95 %	114.08 %
Net Income in million	49	-26	36	186	128
Annual Return On Assets	1.66 %	-0.95 %	1.31 %	7.75 %	5.68 %

RGEN's 5 Years Annual ROA >> Back to RGEN Management Effectiveness >> Compare RGEN ROA to its Competitors

Comment on RGEN's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 1.66 % compared to prior year, due to annual net income growth of % to $48.89 million, while value of Repligen's overall assets grew just by 9.38 % to $2,949.70 million, compared to $2,949.70 a year before.

More Return On Assets Ratios
RGEN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RGEN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RGEN's Competitors
Subscribers only: Roa for Repligen's Suppliers
Subscribers only: Return On Assets for RGEN's Customers

You may also want to know
RGEN's Roi	RGEN's Inventory Turnover Ratio	RGEN's Growth Rates	RGEN's Dividend Comparisons
	RGEN's Profitability Ratios	RGEN's Asset Turnover Ratio	RGEN's Dividend Growth
RGEN's Roe	RGEN's Valuation Ratios	RGEN's Financial Strength Ratios	RGEN's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-10-31T17:28:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.